R
Robert M. Merion
Researcher at University of Michigan
Publications - 301
Citations - 28862
Robert M. Merion is an academic researcher from University of Michigan. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 81, co-authored 297 publications receiving 26529 citations. Previous affiliations of Robert M. Merion include Eli Lilly and Company & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Factors predictive of the discard of ecd kidneys do not predict outcome: 66
Francis L. Delmonico,K OʼConnor,R. Pietroski,K Meyer,George S. Lipkowitz,Jeffrey S. Stoff,Douglas E. Schaubel,Robert M. Merion,Friedrich K. Port,A. B. Leichtman +9 more
Cytomegalovirus and Epstein-Barr virus-acquired immunity after sandoglobulin prophylaxis in the pediatric renal transplant population
John M. Ham,Timothy E. Bunchman,D. A. Campbell,D. B. Kershaw,J. D. Punch,A. B. Sedman,J. G. Turcotte,Robert M. Merion +7 more
Observations on quantitative scintigraphy with deconvolutional analysis in liver transplantation
Robert M. Merion,Darrell A. Campbell,Donald C. Dafoe,Lawrence Rosenberg,Jeremiah G. Turcotte,Jack E. Juni +5 more
Journal ArticleDOI
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy
Sanjiv Harpavat,Kieran Hawthorne,Kenneth D.R. Setchell,Monica Narvaez Rivas,Lisa L. Henn,Charlotte A. Beil,Saul J. Karpen,Vicky L. Ng,Estella M. Alonso,Jorge A. Bezerra,Stephen L. Guthery,Simon Horslen,Kathleen M. Loomes,Patrick J. McKiernan,John C. Magee,Robert M. Merion,Jean P. Molleston,Philip J. Rosenthal,Richard F. Thompson,Kasper S. Wang,Ronald J. Sokol,Benjamin L. Shneider +21 more
TL;DR: Serum bile acid levels may be a useful prognostic biomarker for infants achieving normalized bilirubin levels after KP and during 734 person-years of follow-up, those in the ≤40 μmol/L group were significantly less likely to develop splenomegaly, ascites, gastrointestinal bleeding, or clinically evident portal hypertension.